Research Topics
| Sum LamSummaryAffiliation: St. John's University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetesSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY 11439, USA
Cardiol Rev 18:213-7. 2010..It is also an alternative therapy for patients who have contraindications or intolerability to other antidiabetic agents...- Azilsartan: a newly approved angiotensin II receptor blockerSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, NY, USA
Cardiol Rev 19:300-4. 2011..It is also an option for those patients who have contraindications or cannot tolerate other antihypertensive agents, including dry cough induced by angiotensin-converting enzyme inhibitors... - Vaccines for older adultsSum Lam
St John s University College of Pharmacy and Allied Health Professions, Department of Clinical Pharmcy Practice, Queens, New York 11439, USA
Consult Pharm 24:380-91. 2009..To update senior care pharmacists with current recommendations on influenza, pneumococcal, zoster, and tetanus vaccines for older adults 65 years of age or older... - Strontium ranelate for the management of osteoporosisSum Lam
Department of Clinical Pharmacy Practice, St John s University, Queens, New York, USA
Consult Pharm 23:531-7. 2008..To evaluate the role of strontium ranelate in the management of osteoporosis... - Interferon-beta1b for the treatment of multiple sclerosisSum Lam
St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, St Albert s Hall Room 114, 8000 Utopia Parkway, Queens, New York, NY 11439, USA
Expert Opin Drug Metab Toxicol 4:1111-7. 2008..Multiple sclerosis is a debilitating autoimmune disorder that causes disability in young adults... - Aliskiren: an oral renin inhibitor for the treatment of hypertensionSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
Cardiol Rev 15:316-23. 2007..It is also an option for those patients who have contraindications or intolerability to other antihypertensive agents, including dry cough induced by ACE inhibitors... - Pharmacologic management of overactive bladderSum Lam
St John s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, 8000 Utopia Parkway, St Albert Hall, Room 114, Queens, NY 11439 0001, USA
Clin Interv Aging 2:337-45. 2007..This article summarizes the efficacy, contraindications, precautions, dosing and common side effects of these agents. All available clinical trials on trospium, solifenacin and darifenacin were reviewed to determine its place in therapy... - Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessationSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
Cardiol Rev 15:154-61. 2007..Overall, varenicline is a breakthrough in the management of tobacco addiction and has demonstrated good efficacy in motivated quitters. It also provides an option for smokers who cannot tolerate other pharmacologic interventions... - Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature reviewSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
Pharmacotherapy 26:1169-74. 2006..Cefepime toxicity should be suspected whenever a patient receiving the drug experiences a change in mental status or myoclonus... - Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitusSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
Cardiol Rev 14:205-11. 2006..It is also an alternative therapy for those patients who cannot tolerate other antidiabetic drugs... - Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinicSum Lam
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St. John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA
Am J Health Syst Pharm 62:626-9. 2005 - Sitagliptin: a novel drug for the treatment of type 2 diabetesMary Choy
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Jamaica, New York 11439, USA
Cardiol Rev 15:264-71. 2007..It is also an alternative therapy for those patients who have contraindications or intolerability to other antidiabetic agents... - Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolismTERRY CHEN
Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St John s University, Queens, New York, USA
Cardiol Rev 17:192-7. 2009..It has the major advantages of once daily oral dosing and no required laboratory monitoring, giving it the potential to replace current antithrombotics in the market today... - Disease modifying agents for multiple sclerosisOlga Hilas
St John s University College of Pharmacy and Allied Health Professions, Queens, NY, USA
Open Neurol J 4:15-24. 2010..To summarize major clinical trials which evaluate the efficacy and safety data of approved disease modifying agents for the treatment of various types of multiple sclerosis... - Emerging therapies for the treatment of Helicobacter pylori infectionsTomasz Z Jodlowski
College of Pharmacy and Allied Health Professions, St John s University, 8000 Utopia Parkway, Queens, NY 11439, USA
Ann Pharmacother 42:1621-39. 2008..To describe emerging therapies, such as levofloxacin, moxifloxacin, rifabutin, rifaximin, tinidazole, doxycycline, minocycline, lactoferrin, and plaunotol for the eradication of Helicobacter pylori infection... - Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitusSum Lam
Geriatric Research, Education and Clinical Center GRECC, Veterans Affairs Medical Center, Durham, NC, USA
Heart Dis 5:231-40. 2003..In summary, insulin glargine offers a promising alternative as a once-daily basal insulin therapy in patients with type 1 and type 2 diabetes...